Shawn Patrick O'Brien

Mayne Pharma is an ASX (MYX) listed specialty pharmaceutical company with operations in Australia and the USA. Mayne Pharma International (MPI) is headquartered in Adelaide, South Australia. Our Australian based division offers a full-service CDMO with expertise in pharmaceutical development and scale up from concept to commercialisation, quickly and cost effectively. Our GMP manufacturing facility is TGA and FDA accredited, licensed to handle various scheduled drugs and are well positioned to provide a gateway to global markets. We use our unique oral drug delivery systems to improve formulations and in-license novel medicines from around the world. Through innovation and collaborative partnerships, our products address unmet clinical needs for Australians. Our commercial function in Australia covers a range of speciality prescription and consumer products and is supported by our national team. We are committed to delivering better health outcomes for Australian patients.